BURNETT JOSEPH
CEO and President
BURNETT JOSEPH has filed 13 SEC Form 4 filings (23 transaction rows) across 1 company, with disclosures dating back to 2025. 13 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, BURNETT JOSEPH is listed as CEO and President at ClearPoint Neuro, Inc. Inside the rolling window, BURNETT JOSEPH reported no open-market purchases and 6 open-market sales totaling $2.9M in CLPT. The largest disclosed transaction in the window is a sale of 61,843 CLPT shares on Jun 17, 2026, worth $1.1M.
Companies traded
Other insiders at CLPT
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.9M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has BURNETT JOSEPH made?
BURNETT JOSEPH has filed 13 SEC Form 4 filings (23 transaction rows) across 1 company since 2025.
Which companies does BURNETT JOSEPH trade?
BURNETT JOSEPH has filed SEC Form 4 disclosures for 1 company, including CLPT.
When was BURNETT JOSEPH's most recent SEC Form 4 filing?
BURNETT JOSEPH's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is BURNETT JOSEPH's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, BURNETT JOSEPH is listed as CEO and President.
What is BURNETT JOSEPH's total buy and sell value in the current window?
Inside the rolling retention window, BURNETT JOSEPH bought $0 and sold $2.9M based on SEC Form 4 filings.
What was BURNETT JOSEPH's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 61,843 CLPT shares on 2026-06-17, worth $1.1M, per SEC Form 4 filings.